Clinical Study
Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
Table 2
Hazard ratios with 95% confidence intervals for time to first appropriate shock based on GFR.
| ||||||||||||||||||||||||
*Adjusted for age (≥75 or <75 years), sex, indication for ICD implantation (primary/secondary), NYHA class, heart failure admission, antiarrhythmic/betablocker use, and LVEF (<30%, ≥30%). |